Objective To establish a mouse model which can produce hepatitis C virus(HCV) RNA for examination of the efficiency of virus clearance of high-affinity HCV monoclonal antibody in vivo.Methods Huh7-Jc1 cell model was established by transfecting a genotype 2a HCV plasmid Jc1 into Huh7 cell line which can produce HCV RNA in vitro.The Huh7-Jc1 cell was injected into the nude mouse abdominally or intravenously and/,and the remaining HCV RNA level was detected by optical in vivo imaging and virus RNA in peripheral blood was also detected.Negative control was established by injecting non-HCV Huh7 cell.Results A HCV cell model was estabished which could express HCV RNA and core protein.and the supernatant of the HCV cell model also had the ability to infect the Huh7 cells.And the HCV RNA could be detected in the serum of the BALB/c-nu nude mouse which were implanted with Huh7-Jc1 cell(intraperitoneal or tail intravenous).Conclusion Our data indicates that implanting Huh7-Jc1 cell is a feasible method for building a HCV expressing mouse model,however,a higher efficiency and long-term virus producing mouse model still needed moreresearch.
[1]Sarbah SA,Younossi ZM.Hepatitis C:an update on the silent epidemic[J].J Clin Gastroenterol,2000,30(2):125-143.
|
[2]Hu YW,Rocheleau L,Larke B,et al.Immunoglobulin mimicry by Hepatitis C Virus envelope protein E2[J].Virology,2005,332(2):538-549.
|
[3]Tarr AW,Owsianka AM,Timms JM,et al.Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33[J].Hepatology,2006,43(3):592-601.
|
[4]Tokushige K,Wakita T,Pachuk C,et a1.Expression and lmmume Response to Hepatitis C Virus Core DNA—Base Vaccine Constructs[J].Hepatology,1996,24(1):l4-20.
|
[5]Guévin C,Lamarre A,LabontéP.Novel HCV replication mouse model using human hepatocellular carcinoma xenografts[J].Antiviral Res,2009,84(1):14-22.
|
[6]Lindenbach BD,Evan MJ,Syder AJ,et al.Complete replication of hepatitis C virus in cell culture[J].Science,2005,309(5734):623-626.
|
[7]Zhu N,Ware CF,Lai MM.Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor[J].Virology,2001,283(2):178-187.
|
[8]Chou AH,Tsai HF,Wu YY,et al.Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway[J].J Immunol,2005,174:2160-2166.
|
[1] | Du YiChao, Zhang Hao, Zhong FuRui, Cheng HuanLi, Lai Li, Qian BaoLin, Tan Peng, Xia XianMing, Fu WenGuang. Protective effect of pinocembrin in a mouse model of liver injury induced by acetaminophen[J]. Journal of Clinical Hepatology, 2020, 36(3): 608-611. doi: 10.3969/j.issn.1001-5256.2020.03.027 |
[2] | WANG WenHui, DUAN XuHua, LI Hao, LI FengYao, JU ShuGuang, WANG ManZhou, REN JianZhuang, HAN XinWei. Effect of arsenic trioxide-loaded CalliSpheres beads in the treatment of rabbits with VX2 liver tumor[J]. Journal of Clinical Hepatology, 2020, 36(12): 2730-2734. doi: 10.3969/j.issn.1001-5256.2020.12.018 |
[3] | Wang LiBo, Sun YuLing. Establishment of Budd-Chiari syndrome models and related research advances[J]. Journal of Clinical Hepatology, 2020, 36(4): 908-911. doi: 10.3969/j.issn.1001-5256.2020.04.044 |
[4] | Ha FuShuang, Han Tao, Liang Ning, Nie XinHua, Zhu ZhengYan. Effect of recombinant human granulocyte colony-stimulating factor on rats with acute liver failure[J]. Journal of Clinical Hepatology, 2019, 35(7): 1565-1569. doi: 10.3969/j.issn.1001-5256.2019.07.028 |
[5] | Wang Hao, He Cheng, Chen Hao, Ou YangZhongMin, Liu ZhiQiang. Value of Gd-EOB-DTPA-enhanced MRI in the assessment of liver function in dogs with acute liver failure[J]. Journal of Clinical Hepatology, 2019, 35(7): 1576-1581. doi: 10.3969/j.issn.1001-5256.2019.07.030 |
[6] | Zhang YongChao, Bi YanZhen, Fang Xiao, Wang QuanYi, Wang QuanQuan, Tang HuiXin, Kong LingBin, Chen Yu, Duan ZhongPing, Shu ZhenFeng, Hong Feng. Protective effect of probiotics in rats with acute-on-chronic liver failure and related mechanism[J]. Journal of Clinical Hepatology, 2019, 35(7): 1570-1575. doi: 10.3969/j.issn.1001-5256.2019.07.029 |
[7] | Zhou QiFeng, Zhang LingQiang, Liao MengJiao, Pang MingQuan, Li MengXuan, Ren Li, Fan HaiNing. Establishment of a subcutaneous xenograft tumor model of alveolar echinococcosis in nude mice[J]. Journal of Clinical Hepatology, 2018, 34(3): 588-590. doi: 10.3969/j.issn.1001-5256.2018.03.028 |
[8] | Zhang JiYu, Fan XingLiang. Research advances in the mouse model of primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2017, 33(11): 2235-2238. doi: 10.3969/j.issn.1001-5256.2017.11.041 |
[9] | Wang BaoJu, Zhu Bin, Guo WeiNa, Yang DongLiang. Establishment and application of in vitro and in vivo models of hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2017, 33(8): 1458-1464. doi: 10.3969/j.issn.1001-5256.2017.08.009 |
[10] | Li Dong, Lu ZhongHua, Gan JianHe. Establishment of a rat model of early-stage liver failure and Th17/Treg imbalance[J]. Journal of Clinical Hepatology, 2016, 32(5): 928-932. doi: 10.3969/j.issn.1001-5256.2016.05.025 |
[11] | Chen Jing, Liu XiaoYan, Yang HaoZhen, Huang Kun, Hu JinHua, Xin ShaoJie. Study on p-p38 expression and its significance in liver tissues of mice with acute liver failure and patients with HBV-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2015, 31(4): 556-559. doi: 10.3969/j.issn.1001-5256.2015.04.019 |
[12] | Pang GuoJin, Chen ShuangJun, Zhao WeiHua, Liu TianHui, Wang Ping, You Hong, Cong Min. Dynamic change of hepcidin in liver fibrosis induced by CCl4 among mice[J]. Journal of Clinical Hepatology, 2015, 31(3): 418-423. doi: 10.3969/j.issn.1001-5256.2015.03.025 |
[13] | Zhu Ting, Nie QingHe. New progress in development of animal models of hepatitis C virus infection[J]. Journal of Clinical Hepatology, 2015, 31(1): 123-126. doi: 10.3969/j.issn.1001-5256.2015.01.028 |
[14] | Zhang YanFang, Zhao DongMei, Zhang YanMin, Wang Wei, Zhao HongRu. An analysis of related factors for hepatitis C genotyping and sustained virologic response in Xingtai, China[J]. Journal of Clinical Hepatology, 2015, 31(11): 1845-1848. doi: 10.3969/j.issn.1001-5256.2015.11.018 |
[15] | Huang HaiYan, Xin YongNing, Jiang Man, Jin WenWen, Jiang XiangJun, Xuan ShiYing. Research advances in animal models of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2014, 30(9): 948-953. doi: 10.3969/j.issn.1001-5256.2014.09.028 |
[16] | Yang RuiFeng, Wei Lai. Detection of hepatitis C virus infection[J]. Journal of Clinical Hepatology, 2011, 27(1): 1-7. |
[17] | Jiang Han, Wang XueFeng, Wang ZiHao, Xu Bin, Shi WeiBin. The establishment of rabbit VX2 hepatic tumor model and the application of nano-scale microbubble contrast agent in the diagnosis of this model[J]. Journal of Clinical Hepatology, 2011, 27(7): 746-748. |
[18] | Ye LiHong, Wang ChongKui, Tian YueYang, Xu Yi, Zheng HaoJie, Shao ShiXiang, Dai ErHei. Effect of Ruangan Huajian granule on hepatic expression of PDGF - B in C57 mice with experimental hepatic fibrosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1047-1050. |
[19] | Sun LinLin, Shi Jun, Hao JingHua, Ren WanHua, Yan ChunYing, Zhang Jie, Lin XiaoYan, Cui Bin. Effect of high-fat diet on establishment of a rat non-alcoholic steatohepatitis/liver fibrosis model[J]. Journal of Clinical Hepatology, 2011, 27(3): 254-257+272. |
[20] | Song Yu, Yu Zheng, Fan YanHua, Yao ShuKun, Wang TaiLing. A rat model of hepatic veno-occlusive disease induced by the Gynura root water decoction[J]. Journal of Clinical Hepatology, 2011, 27(8): 860-864. |